Skip to main content

Thyroid hormone therapy for hypothyroidism

Abstract

The purpose of this article will be to review the basics of thyroid hormone therapy, including various thyroid hormone formulations, the institution and monitoring of thyroid hormone therapy, adverse effects of overtreatment, the management of patients with persistent symptoms despite normal thyroid function tests, and potential new innovations in thyroid hormone therapy. The conclusions support the necessity to personalize thyroid hormone replacement therapy in hypothyroid patients.

This is a preview of subscription content, access via your institution.

References

  1. A. Gruters, H. Krude, Detection and treatment of congenital hypothyroidism. Nat. Rev. Endocrinol. 18, 104–113 (2012)

    Article  CAS  Google Scholar 

  2. W.M. Tunbridge, D.C. Evered, R. Hall et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin. Endocrinol. 7, 481–493 (1977)

    Article  CAS  Google Scholar 

  3. J.G. Hollowell, N.W. Staehling, W.D. Flanders et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 87, 489–499 (2002)

    Article  CAS  PubMed  Google Scholar 

  4. G.J. Canaris, N.R. Manowitz, G. Mayor, E.C. Ridgway, The Colorado thyroid disease prevalence study. Arch. Intern. Med. 160, 526–534 (2000)

    Article  CAS  PubMed  Google Scholar 

  5. J. Doucet, C. Trivalle, P. Chassagne et al. Does age play a role in clinical presentation of hypothyroidism? J. Am. Geriatr. Soc. 42, 984–986 (1994)

    Article  CAS  PubMed  Google Scholar 

  6. B. Biondi, A.R. Cappola, D.S. Cooper, Subclinical Hypothyroidism: A Review. JAMA 322, 153–160 (2019).

    Article  CAS  PubMed  Google Scholar 

  7. A.P. Bremner, P. Feddema, P.J. Leedman et al. Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J. Clin. Endocrinol. Metab. 97, 1554–62 (2012)

    Article  CAS  PubMed  Google Scholar 

  8. T. Vadiveloo, P.T. Donnan, M.J. Murphy, G.P. Leese, Age- and gender-specific TSH reference intervals in people with no obvious thyroid disease in Tayside, Scotland: the thyroid epidemiology, audit, and research study (TEARS). J. Clin. Endocrinol. Metab. 98, 1147–1153 (2013)

    Article  CAS  PubMed  Google Scholar 

  9. H.S. Ahn, D.W. Kim, Y.J. Lee, H.J. Baek, J.H. Ryu, Diagnostic accuracy of real-time sonography in differentiating diffuse thyroid disease from normal thyroid parenchyma: a multicenter study. AJR Am. J. Roentgenol. 211, 649–654 (2018)

    Article  PubMed  Google Scholar 

  10. O. Koulouri, C. Moran, D. Halsall, K. Chatterjee, M. Gurnell, Pitfalls in the measurement and interpretation of thyroid function tests. Best. Pract. Res. Clin. Endocrinol. Metab. 27, 745–762 (2013)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. N. Hattori, T. Ishihara, K. Yamagami, A. Shimatsu, Macro TSH in patients with subclinical hypothyroidism. Clin. Endocrinol. 83, 923–930 (2015)

    Article  CAS  Google Scholar 

  12. J.R. Garber, R.H. Cobin, H. Gharib, American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults et al., Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid 22, 1200–1235 (2012).

    Article  CAS  PubMed  Google Scholar 

  13. J. Jonklaas, A.C. Bianco, A.J. Bauer, American Thyroid Association Task Force on Thyroid Hormone Replacement et al., Guidelines for the treatment of hypothyroidism: prepared by the American thyroid association task force on thyroid hormone replacement. Thyroid 24, 1670–751 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  14. B. Biondi, D.S. Cooper, The clinical significance of subclinical thyroid dysfunction. Endocr. Rev. 29, 76–131 (2008)

    Article  CAS  PubMed  Google Scholar 

  15. D.S. Cooper, B. Biondi, Subclinical thyroid disease. Lancet 379(9821), 1142–1154 (2012)

    Article  PubMed  Google Scholar 

  16. N. Rodondi, W.P. den Elzen, D.C. Bauer, Thyroid Studies Collaboration et al., Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304, 1365–1374 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. B. Gencer, T.H. Collet, V. Virgini, Thyroid Studies Collaboration et al., Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation 126, 1040–1049 (2012).

    Article  CAS  PubMed  Google Scholar 

  18. S.H. Pearce, G. Brabant, L.H. Duntas et al. 2013 ETA guideline: management of subclinical hypothyroidism. Eur. Thyroid J. 2, 215–218 (2013)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. G. Brenta, M. Vaisman, J.A. Sgarbi et al. Task Force on Hypothyroidism of the Latin American Thyroid Society (LATS). Clinical practice guidelines for the management of hypothyroidism. Arq. Bras. Endocrinol. Metabol. 57, 265–291 (2013)

  20. G.E. Bekkering, T. Agoritsas, L. Lytvyn et al. Thyroid hormones treatment for subclinical hypothyroidism : a clinical practice guideline. BMJ 14(365), l2006 (2019)

    Article  Google Scholar 

  21. J. Lazarus, R.S. Brown, C. Daumerie, A. Hubalewska-Dydejczyk, R. Negro, B. Vaidya,European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur. Thyroid J. 3, 76–94 (2014)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. E.K. Alexander, E.N. Pearce, G.A. Brent et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 27, 315–389 (2017)

    Article  PubMed  Google Scholar 

  23. M. Fleseriu, J.A. Hashim, N. Karavitaki et al. Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101, 3888–3921 (2016)

    Article  CAS  PubMed  Google Scholar 

  24. B. Biondi, L. Wartofsky, Treatment with thyroid hormone. Endocr. Rev. 35, 433–512 (2014)

    Article  CAS  PubMed  Google Scholar 

  25. T.D. Hoang, C.H. Olsen, V.Q. Mai, P.W. Clyde, M.K. Shakir, Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism:a randomized, double-blind, crossover study. J. Clin. Endocrinol. Metab. 98, 1982–1990 (2013)

    Article  CAS  PubMed  Google Scholar 

  26. B. Biondi, L. Bartalena, L. Chiovato et al. “Recommendations for treatment of hypothyroidism with levothyroxine and levotriiodothyronine: a 2016 position statement of the Italian Society of Endocrinology and the Italian Thyroid Association”. J. Endocrinol. Investig. 39, 1465–1474 (2016)

    Article  CAS  PubMed  Google Scholar 

  27. J.I. Mechanick, E.M. Brett, A.B. Chausmer, R.A. Dickey, S. Wallach, American Association of Clinical Endocrinologists, American Association of Clinical Endocrinologists medical guidelines for the clinical use of dietary supplements and nutraceuticals. Endocr. Pract. 9, 417–470 (2003).

    Article  PubMed  Google Scholar 

  28. L.E. Braverman, S.H. Ingbar, K. Sterling, Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J. Clin. Investig. 49, 855–864 (1970)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. R. Vita, S. Benvenga, Tablet levothyroxine (l-T4) malabsorption induced by proton pump inhibitor; a problem that was solved by switching to l-T4 in soft gel capsule. Endocr. Pract. 20, e38–41 (2014)

    Article  PubMed  Google Scholar 

  30. C. Virili, P. Trimboli, F. Romanelli, M. Centanni, Liquid and softgel levothyroxine use in clinical practice: state of the art. Endocrine 54, 3–14 (2016)

    Article  CAS  PubMed  Google Scholar 

  31. J.V. Hennessey, A.O. Malabanan, B.R. Haugen, E.G. Levy, Adverse event reporting in patients treated with levothyroxine: results of the pharmacovigilance task force survey of the American Thyroid Association, American Association of Clinical Endocrinologists, and the Endocrine Society. Endocr. Pract. 16, 357–370 (2010)

    Article  PubMed  Google Scholar 

  32. L. Wartofsky, Levothyroxine: therapeutic use and regulatory issues related to bioequivalence. Expert Opin. Pharmacother. 3, 727–732 (2002)

    Article  CAS  PubMed  Google Scholar 

  33. F.S. Celi, M. Zemskova, J.D. Linderman et al. Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine. J. Clin. Endocrinol. Metab. 96, 3466–3474 (2011)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. W.M. Wiersinga, L. Duntas, V. Fadeyev, B. Nygaard, M.P. Vanderpump, ETA guidelines: the use of l-T4 + l-T3 in the treatment of hypothyroidism. Eur. Thyroid J. 1, 55–71 (2014)

    Article  Google Scholar 

  35. L. Bartalena, E. Martino, A. Pacchiarotti et al. Factors affecting suppression of endogenous thyrotropin secretion by thyroxine treatment: retrospective analysis in athyreotic and goitrous patients. J. Clin. Endocrinol. Metab. 64, 849–855 (1987)

    Article  CAS  PubMed  Google Scholar 

  36. L. Persani, Clinical review: central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges. J. Clin. Endocrinol. Metab. 97, 3068–3078 (2012)

    Article  CAS  PubMed  Google Scholar 

  37. J. Jonklaas, Sex and age differences in levothyroxine dosage requirement. Endocr. Pract. 16, 71–79 (2010)

    Article  PubMed  Google Scholar 

  38. F. Santini, A. Pinchera, A. Marsili et al. Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases. J. Clin. Endocrinol. Metab. 90, 124–127 (2005)

    Article  CAS  PubMed  Google Scholar 

  39. M. Devdhar, R. Drooger, M. Pehlivanova, G. Singh, J. Jonklaas, Levothyroxine replacement doses are affected by gender and weight, but not age. Thyroid 21, 821–827 (2011)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. V. Fonseca, M. Thomas, A. Katrak, P. Sweny, J.F. Moorhead, Can urinary thyroid hormone loss cause hypothyroidism? Lancet 24(8765), 475–476 (1991). 338

    Article  Google Scholar 

  41. N.A. Junglee, M.F. Scanlon, D.A. Rees, Increasing thyroxine requirements in primary hypothyroidism: don't forget the urinalysis! J. Postgrad. Med. 52, 201–203 (2006)

    CAS  PubMed  Google Scholar 

  42. N. Jassam, T.J. Visser, T. Brisco et al. Consumptive hypothyroidism: a case report and review of the literature. Ann. Clin. Biochem. 48, 186–189 (2011)

    Article  CAS  PubMed  Google Scholar 

  43. J.W. De Groot, T.P. Links, W.T. van der Graaf, Tyrosine kinase inhibitors causing hypothyroidism in a patient on levothyroxine. Ann. Oncol. 17, 1719–1720 (2006)

    Article  PubMed  Google Scholar 

  44. P. Kundra, K.D. Burman, The effect of medications on thyroid function tests. Med. Clin. North Am. 96, 283–295 (2012)

    Article  CAS  PubMed  Google Scholar 

  45. M. Skelin, T. Lucijanić, D. Amidžić Klarić et al. Factors affecting gastrointestinal absorption of levothyroxine: a review. Clin. Ther. 39, 378–403 (2017)

    Article  CAS  PubMed  Google Scholar 

  46. L. Liwanpo, J.M. Hershman, Conditions and drugs interfering with thyroxine absorption. Best. Pract. Res Clin. Endocrinol. Metab. 23, 781–792 (2009)

    Article  CAS  PubMed  Google Scholar 

  47. J.C. Morris, How do you approach the problem of TSH elevation in a patient on highdose thyroid hormone replacement? Clin. Endocrinol. 70, 671–673 (2009)

    Article  Google Scholar 

  48. T.G. Bach-Huynh, B. Nayak, J. Loh, S. Soldin, J. Jonklaas, Timing of levothyroxine adminis-tration affects serum thyrotropin concentration. J. Clin. Endocrinol. Metab. 94, 3905–3912 (2009)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. N. Bolk, T.J. Visser, J. Nijman et al. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch. Intern. Med. 170, 1996–2003 (2010)

    Article  CAS  PubMed  Google Scholar 

  50. H.M. Robertson, A.K. Narayanaswamy et al. Factors contributing to high levothyroxine doses in primary hypothyroidism: an interventional audit of a large community database. Thyroid 24, 1765–1771 (2014)

    Article  CAS  PubMed  Google Scholar 

  51. M. Centanni, L. Gargano, G. Canettieri et al. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N. Engl. J. Med. 354, 1787–1795 (2006)

    Article  CAS  PubMed  Google Scholar 

  52. S. Benvenga, L. Bartolone, M.A. Pappalardo et al. Altered intestinal absorption of l-thyroxine caused by coffee. Thyroid 18, 293–301 (2008)

    Article  CAS  PubMed  Google Scholar 

  53. P. Gargiulo, L. Gargano, M. Centanni, Atypical celiac disease as cause of increased need for thyroxine: a systematic study. J. Clin. Endocrinol. Metab. 97, E419–422 (2012)

    Article  CAS  PubMed  Google Scholar 

  54. M. Cellini, M.G. Santaguida, I. Gatto et al. Systematic appraisal of lactose intolerance as cause of increased need for oral thyroxine. J. Clin. Endocrinol. Metab. 99(8), E1454–1458 (2014)

    Article  CAS  PubMed  Google Scholar 

  55. S.K. Grebe, R.R. Cooke, H.C. Ford, J.N. Fagerström, D.P. Cordwell, N.A. Lever, G.L. Purdie, C.M. Feek, Treatment of hypothyroidism with once weekly thyroxine. J. Clin. Endocrinol. Metab. 82, 870–875 (1997)

    CAS  PubMed  Google Scholar 

  56. C. Virili, M. Centanni, Does microbiota composition affect thyroid homeostasis? Endocrine 49, 583–587 (2015)

    Article  CAS  PubMed  Google Scholar 

  57. A. Lobasso, L. Nappi, L. Barbieri et al. Severe hypothyroidism due to the loss of therapeutic efficacy of l-thyroxine in a patient with esophageal complication associated with systemic sclerosis. Front. Endocrinol. (Lausanne) 8, 241 (2017)

    Article  Google Scholar 

  58. M. McMillan, K.S. Rotenberg, K. Vora et al. Comorbidities, concomitant medications, and diet as factors affecting. Levothyroxine therapy: results of the CONTROL surveillance project. Drugs R D 16, 53–68 (2016)

    Article  CAS  PubMed  Google Scholar 

  59. S.A. Irving, T. Vadiveloo, G.P. Leese, Drugs that interact with levothyroxine: an observational study from the Thyroid Epidemiology, Audit and Research Study (TEARS). Clin. Endocrinol 82, 136–141 (2015)

    Article  CAS  Google Scholar 

  60. M.G. Santaguida, C. Virili, S.C. Del Duca et al. Thyroxine softgel capsule in patients with gastric-related T4 malabsorption. Endocrine 49, 51–57 (2015)

    Article  CAS  PubMed  Google Scholar 

  61. C. Virili, L. Giovanella, P. Fallahi et al. Levothyroxine therapy: changes of TSH levels by switching patients from tablet to liquid formulation. a systematic review and meta-analysis. Front. Endocrinol. 9, 10 (2018)

    Article  Google Scholar 

  62. R. Vita, G. Saraceno, F. Trimarchi, S. Benvenga, Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors. J. Clin. Endocrinol. Metab. 99, 4481–4486 (2014)

    Article  CAS  PubMed  Google Scholar 

  63. R. Vita, G. Saraceno, F. Trimarchi, S. Benvenga, A novel formulation of l-thyroxine (T4) reduces the problem of T4 malabsorption by coffee observed with traditional tablet formulations. Endocrine 43, 154–160 (2013)

    Article  CAS  PubMed  Google Scholar 

  64. C. Cappelli, I. Pirola, L. Daffini et al. A double-blind placebo-controlled trial of liquid thyroxine ingested at breakfast: results of the TICO study. Thyroid 26, 197–202 (2016)

    Article  CAS  PubMed  Google Scholar 

  65. P. Fierabracci, S. Martinelli, A. Tamberi et al. Weight loss and variation of levothyroxine requirements in hypothyroid obese patients after bariatric surgery. Thyroid 26, 499–503 (2016)

    Article  CAS  PubMed  Google Scholar 

  66. S. Gadiraju, C.J. Lee, D.S. Cooper, Levothyroxine dosing following bariatric surgery. Obes. Surg. 26, 2538–2542 (2016)

    Article  PubMed  Google Scholar 

  67. K.B. Ain, S. Refetoff, H.G. Fein, B.D. Weintraub, Pseudomalabsorption of levothyroxine. JAMA 266, 2118–1220 (1991)

    Article  CAS  PubMed  Google Scholar 

  68. D.J. Lips, M.T. van Reisen, V. Voigt, W. Venekamp, Diagnosis and treatment of pseudomalabsorption. Neth. J. Med. 62, 114–118 (2004)

    CAS  PubMed  Google Scholar 

  69. J.N. Walker, P. Shillo, V. Ibbotson et al. A thyroxine absorption test followed by weekly thyroxine administration: a method to assess non-adherence to treatment. Eur. J. Endocrinol. 168, 913–917 (2013)

    Article  CAS  PubMed  Google Scholar 

  70. S. Rangan, A.A. Tahrani, A.F. Macleod, P.K. Moulik, Once weekly thyroxine treatment as a strategy to treat non-compliance. Postgrad. Med J. 83(984), e3 (2007)

    Article  CAS  PubMed  Google Scholar 

  71. V. Eligar, P.N. Taylor, O.E. Okosieme, G.P. Leese, C.M. Dayan, Thyroxine replacement: a clinical endocrinologist's viewpoint. Ann. Clin. Biochem. 53(Pt 4), 421–433 (2016)

    Article  CAS  PubMed  Google Scholar 

  72. K. Andersson, A. Melander, C. Svensson, O. Lind, J.L. Nilsson, Repeat prescriptions: refill adherence in relation to patient and prescriber characteristics, reimbursement level and type of medication. Eur. J. Public Health 15, 621–626 (2005)

    Article  PubMed  Google Scholar 

  73. L.L. Somwaru, A.M. Arnold, N. Joshi, L.P. Fried, A.R. Cappola, High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. J. Clin. Endocrinol. Metab. 94, 1342–1345 (2009)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. C.T. Sawin, T. Herman, M.E. Molitch, M.H. London, S.M. Kramer, Aging and the thyroid. Decreased requirement for thyroid hormone in older hypothyroid patients. Am. J. Med. 75, 206–209 (1983)

    Article  CAS  PubMed  Google Scholar 

  75. T.O. Obisesan, M.H. Aliyu, V. Bond, R.G. Adams, A. Akomolafe, C.N. Rotimi, Ethnic and age-related fat free mass loss in older Americans: the Third National Health and Nutrition Examination Survey (NHANES III). BMC Public Health 5, 41 (2005)

    Article  PubMed  PubMed Central  Google Scholar 

  76. M.T. Hays, K.R. Nielsen, Human thyroxine absorption: age effects and methodological analyses. Thyroid 4, 55–64 (1994)

    Article  CAS  PubMed  Google Scholar 

  77. M. Centanni, M. Marignani, L. Gargano et al. Atrophic body gastritis in patients with autoimmune thyroid disease: an underdiagnosed association. Arch. Intern Med. 159, 1726–1730 (1999)

    Article  CAS  PubMed  Google Scholar 

  78. S. Checchi, A. Montanaro, L. Pasqui et al. l-thyroxine requirement in patients with autoimmune hypothyroidism and parietal cell antibodies. J. Clin. Endocrinol. Metab. 93, 465–469 (2008)

    Article  CAS  PubMed  Google Scholar 

  79. J.J. Scargill, M. Livingston, D. Holland, C.J. Duff, A.A. Fryer, A.H. Heald, Monitoring thyroid function in patients on levothyroxine. Assessment of Conformity to National Guidance and Variability in Practice. Exp. Clin. Endocrinol. Diabetes 125, 625–633 (2017)

    Article  CAS  PubMed  Google Scholar 

  80. U.M. Kabadi, Variability of l-thyroxine replacement dose in elderly patients with primary hypothyroidism. J. Fam. Pract. 24, 473–477 (1987)

    CAS  PubMed  Google Scholar 

  81. P.N. Taylor, C. Minassian, R.A. Rehman et al. TSH levels and risk of miscarriage in women on long-term levothyroxine: a community-based study. J. Clin. Endocrinol. Metab. 99, 3895–902 (2014)

    Article  CAS  PubMed  Google Scholar 

  82. R.W. Flynn, S.R. Bonellie, R.T. Jung, T.M. MacDonald, A.D. Morris, G.P. Leese, Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J. Clin. Endocrinol. Metab. 95, 186–193 (2010)

    Article  CAS  PubMed  Google Scholar 

  83. E.N. Klein Hesselink, M.S. Klein Hesselink, G.H. de Bock et al. Long-term cardiovascular mortality in patients with differentiated thyroid carcinoma: an observational study. J. Clin. Oncol. 31, 4046–4053 (2013)

    Article  PubMed  Google Scholar 

  84. M.R. Blum, D.C. Bauer, T.H. Collet, H.A. Fink,Thyroid Studies Collaboration et al., Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA 313, 2055–2065 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  85. K.H. Winther, P. Cramon, T. Watt et al. Disease-specific as well as generic quality of life is widely impacted in autoimmune hypothyroidism and improves during the first six months of levothyroxine therapy. PLoS ONE 11, e0156925 (2016)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. E.A. McAninch, A.C. Bianco, The history and future treatment of hypothyroidism. Ann. Intern. Med. 164, 50–56 (2016)

    Article  PubMed  PubMed Central  Google Scholar 

  87. S.J. Peterson, A.R. Cappola, M.R. Castro et al. Degrees of satisfaction and coexistent diseases in those responding to a survey exploring perceptions about treatment of hypothyroidism. Thyroid 28, 707–721 (2018)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. L.F. Michaelsson, B.B. Medici, J.L. la Cour et al. Treating hypothyroidism with thyroxine/triiodothyronine combination therapy in Denmark: following guidelines or following trends?. Eur. Thyroid J. 4, 174–180 (2015)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. J. Jonklaas, E. Tefera, N. Shara, Physician choice of hypothyroidism therapy: influence of patient characteristics. Thyroid 28, 1416–1424 (2018)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. O. Okosieme, J. Gilbert, P. Abraham et al. Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee. Clin. Endocrinol. 84, 799–808 (2016)

    Article  Google Scholar 

  91. J. Jonklaas, B. Davidson, S. Bhagat, S.J. Soldin, Triiodothyronine levels in athyreotic individuals during levothyroxine therapy. JAMA 299, 769–777 (2008)

    Article  CAS  PubMed  Google Scholar 

  92. M. Ito, A. Miyauchi, S. Morita T et al. TSH-suppressive doses of levothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who have undergone total thyroidectomy. Eur. J. Endocrinol. 167, 373–378 (2012)

    Article  CAS  PubMed  Google Scholar 

  93. J. Jonklaas, Persistent hypothyroid symptoms in a patient with a normal thyroid stimulating hormone level. Curr. Opin. Endocrinol. Diabetes Obes. 24, 356–363 (2017)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. A.C. Biancom, B.W. Kim, Deiodinases: implications of the local control of thyroid hormone action. J. Clin. Investig. 116, 2571–2579 (2006)

    Article  CAS  Google Scholar 

  95. A.C. Bianco, Pathophysiological relevance of deiodinase polymorphism. Curr. Opin. Endocrinol. Diabetes Obes. 25, 341–346 (2018). BW

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. B.C. Appelhof, R.P. Peeters, W.M. Wiersinga et al. Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3'-triiodothyronine therapy. J. Clin. Endocrinol. Metab. 90, 6296–6299 (2005)

    Article  CAS  PubMed  Google Scholar 

  97. A. Carle, J. Faber, R. Steffensen, P. Laurberg, B. Nygaard, Hypothyroid patients encoding combined MCT10 and DIO2 gene polymorphisms may prefer l-T3 + l-T4 combination treatment—data using a blind, randomized clinical study. Eur. Thyroid J. 6, 143–151 (2017)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. W.M. Wiersinga, Therapy of endocrine disease: T4 + T3 combination therapy: is there a true effect? Eur. J. Endocrinol. 177, R287–R296 (2017)

    Article  CAS  PubMed  Google Scholar 

  99. J.C. Galofré, J.J. Díez, D.S. Cooper, Thyroid dysfunction in the era of precision medicine. Endocrinol. Nutr. 63(7), 354–363 (2016)

    Article  PubMed  Google Scholar 

  100. P.W. Ladenson, Precision medicine comes to thyroidology. J. Clin. Endocrinol. Metab. 101, 799–803 (2016)

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bernadette Biondi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Biondi, B., Cooper, D.S. Thyroid hormone therapy for hypothyroidism. Endocrine 66, 18–26 (2019). https://doi.org/10.1007/s12020-019-02023-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-019-02023-7